(Q48484957)

11 February 2018

title

Long-term treatment with pramipexole in restless legs syndrome (English)

1 reference

11 February 2018

1

J Montplaisir

1 reference

11 February 2018

author name string

M L Fantini

2

1 reference

11 February 2018

A Desautels

3

1 reference

11 February 2018

M Michaud

4

1 reference

11 February 2018

D Petit

5

1 reference

11 February 2018

D Filipini

6

1 reference

11 February 2018

publication date

1 December 2006

1 reference

11 February 2018

European Journal of Neurology

published in

1 reference

11 February 2018

volume

13

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

page(s)

1306-1311

1 reference

11 February 2018

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Effects of immobility on sensory and motor symptoms of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Circadian rhythm of restless legs syndrome: relationship with biological markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Restless legs syndrome: clinicoetiologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Sleep laboratory diagnosis of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Dopaminergic treatment of restless legs and rebound phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Restless legs syndrome improved by pramipexole: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Effective cabergoline treatment in idiopathic restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

A randomized controlled study of pergolide in patients with restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Long-term effects of pergolide in the treatment of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Pergolide use in Parkinson disease is associated with cardiac valve regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Parkinson's disease and sleepiness: an integral part of PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Daytime sleepiness, agonist therapy, and driving in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01459.X

10.1111/J.1468-1331.2006.01459.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018